ZYVERSA THERAPEUTICS, INC. Investment Income, Interest
ZYVERSA THERAPEUTICS, INC. (ZVSA) reported Investment Income, Interest of $463.64 thousand for the 9-month period ending 2022-09-30, per its 10-Q filed 2022-11-14.
Discontinued › Income Statement › Other Income
us-gaap:InvestmentIncomeInterest · last filed 2022-11-14
- ZYVERSA THERAPEUTICS, INC. investment income, interest for the quarter ending 2022-09-30 was $354.07K.
- ZYVERSA THERAPEUTICS, INC. investment income, interest for the quarter ending 2022-06-30 was $105.11K.
- ZYVERSA THERAPEUTICS, INC. investment income, interest for the quarter ending 2022-03-31 was $4.45K.
| Period end | Investment Income, Interest 3 month | Investment Income, Interest 6 month | Investment Income, Interest 9 month |
|---|---|---|---|
| 2022-09-30 | $354.07K derived: 10-Q 9 month − 10-Q 6 month · filed 2022-11-14 | $459.18K derived: sum of 2 quarters · filed 2022-11-14 | $463.64K 10-Q · filed 2022-11-14 |
| 2022-06-30 | $105.11K derived: 10-Q 6 month − 10-Q 3 month · filed 2022-08-15 | $109.57K 10-Q · filed 2022-08-15 | |
| 2022-03-31 | $4.45K 10-Q · filed 2022-05-13 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| BioXcel Therapeutics, Inc. (BTAI) | United States | $0.002B | |
| Matinas BioPharma Holdings, Inc. (MTNB) | United States | $0.003B | |
| JUPITER NEUROSCIENCES, INC. (JUNS) | United States | $0.002B | -0.02 |
| ORAGENICS INC (OGEN) | United States | $0.002B | |
| Petros Pharmaceuticals, Inc. (PTPI) | United States | $0.003B | |
| GeoVax Labs, Inc. (GOVX) | United States | $0.003B | -0.45 |
| Nexentis Technologies Inc. (NXTS) | $0.002B | ||
| Decoy Therapeutics Inc. (DCOY) | United States | $0.002B | -0.27 |
| Silo Pharma, Inc. (SILO) | United States | $0.003B | -1.57 |
| Genprex, Inc. (GNPX) | United States | $0.003B | -0.02 |